Latest Articles

Rare Disease Academy 2.0/ Spotting the Signs: A guide to Early Diagnosis and a Timely Refferals

Spot early signs of Pompe, Gaucher, Fabry, ASMD & MPS I. A Sanofi guide to early diagnosis and timely referrals for rare lysosomal storage disorders.

The Clues Behind Recurrent Hernias

Differencial Diagnosis of Recurrent Hernia with joint Contracture or Juvenile Idiopathic Arthritis/ Dr. Nuha Al Zaaby

Importance of Therapeutic Management of Quality of Life among Patients with Atopic Disorders

Management of ALLERGIC FUNGAL RHINOSINUSITIS (AFRS): A sever type 2 Inflammatory Disease

The management of AFRS remains challenging to reduce disease burden and limit potential structural damage complications

From Registry to Reality: Reduced Stroke Incidence with Agalsidase Beta in Fabry Disease

Tolerability of Accelerated Agalsidase Beta Infusions in Fabry Disease: The SHORTEN Study Analysis

Fabry Disease in Cardiology Practice: From Red Flags to Diagnosis

FLUNITY-HD

The FLUNITY-HD Study is the largest individually randomized influenza vaccine effectiveness study and the first of its kind for an influenza vaccine. The study demonstrates the superior benefit of HD-IIV, specifically developed for older adults, compared with SD-IIV against a wide range of hospitalization outcomes in a prespecified and powered analysis encompassing nearly half a million participants. Providing the high-quality data, this study provides further critical evidence that widespread use of HD-IIV could substantially reduce the burden of influenza on both older adults and healthcare systems globally.

Epidemiology and Healthcare Burden Attributable to Laboratory-Confirmed RSV Cases Among Children Under Five Years Old in Saudi Arabia

An overview of the latest Saudi evidence presented at ESPID 2026.